Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study

Background: Subcutaneous immunoglobulin G (SCIG) may be a better option than intravenous immunoglobulin G (IVIG) for patients with primary immunodeficiencies (PID) due to reduced systemic and serious adverse reactions and easier administration. The Infusione Bimensile di Immunoglobuline Sottocute (I...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Pediatr Allergy Immunol Pulmonol
Main Authors: Canessa, Clementina, Gallo, Vera, Pignata, Claudio, Trizzino, Antonino, Graziani, Simona, Martire, Baldassarre, Moschese, Viviana, Palladino, Valentina, Boggia, Giorgio Maria, Matucci, Andrea, Pecoraro, Antonio, Spadaro, Giuseppe, Vultaggio, Alessandra, Azzari, Chiara
Format: Artigo
Sprog:Inglês
Udgivet: Mary Ann Liebert, Inc., publishers 2019
Fag:
Brief Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6733055/
https://ncbi.nlm.nih.gov/pubmed/31508259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ped.2018.0967
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker